The Pharma stocks are positive due to multiple approvals of US FDA for different medicines. The companies are also manufacturing the drugs for the primary treatment of Covid-19. Dr Reddy's Laboratories reclaimed the tag of being the second most valuable listed pharmaceutical company. Sun Pharma is the most valued listed company of India with the market cap of Rs 1.26lakh cr. With a favourable ruling in the appeals court, the odds of launching gVascepa also rise considerably. Bristol Myers Squibb had inked a patent settlement with Dr. Reddy’s Laboratories, allowing the Indian generics company to start with a “volume-limited” launch sometime after March 2022. The exact date of the rollout, and amount of generic Revlimid Dr. Reddy’s will be allowed to sell, are confidential. But on January 31, 2026, the company will have a license to sell its generic Revlimid with no limits. #MOMarketUpdates #IndianStockMarket #MotilalOswal #NiftyPharma #NSE #BSE #Recommendation #Stocktip #Stockrecommendation
Posted on : 18 Sep 2020 5:44 PM
#ResultUpdate: TATA POWER: Hit by higher cost at coal JVs and Mundra; HPC recommendations can provide relief. Read the full 3QFY19 result report here: http://ow.ly/kAKa30nuo8A #ResultUpdate
Posted on : 29 Jan 2019 11:29 AM
Categories
Stock Broker
Financial Consultant
Financial Planner
Online Share Trading Centre
Brokers & Investment Firm
Tags
Motilal Oswal
Motilal Oswal Near me
Motilal Oswal mutual fund office near me
Best Stock broker near me
Mutual funds
IPO investment
Equity trading
Online share trading
BSE sensex
Portfolio management services
Investment bonds
Best SIP plans
Best mutual funds for SIP
Commodity market
Currency market
Open demat account
Online trading account
Open trading account
Investment bonds
Financial advisory services
Stock broker in Kanpur Nagar
Best Portfolio managements services in Kanpur Nagar